These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Magnetic resonance in the diagnosis and treatment of multiple sclerosis]. Rovira Cañellas A Neurologia; 2000; 15(7):288-302. PubMed ID: 11075577 [TBL] [Abstract][Full Text] [Related]
4. Imaging of inflammation in the peripheral and central nervous system by magnetic resonance imaging. Stoll G; Bendszus M Neuroscience; 2009 Feb; 158(3):1151-60. PubMed ID: 18651996 [TBL] [Abstract][Full Text] [Related]
5. Characteristic neuroimaging in patients with tumefactive demyelinating lesions exceeding 30 mm. Kiriyama T; Kataoka H; Taoka T; Tonomura Y; Terashima M; Morikawa M; Tanizawa E; Kawahara M; Furiya Y; Sugie K; Kichikawa K; Ueno S J Neuroimaging; 2011 Apr; 21(2):e69-77. PubMed ID: 20572907 [TBL] [Abstract][Full Text] [Related]
6. MR in the diagnosis and monitoring of multiple sclerosis: an overview. Rovira A; León A Eur J Radiol; 2008 Sep; 67(3):409-14. PubMed ID: 18434066 [TBL] [Abstract][Full Text] [Related]
7. Is it possible to detect active multiple sclerosis plaques using MR thermometry techniques? Demir CF; İnci MF; Özkan F; Özdemir HH Med Hypotheses; 2013 Mar; 80(3):321-4. PubMed ID: 23312112 [TBL] [Abstract][Full Text] [Related]
8. Serial gadolinium-enhanced and magnetization transfer imaging to investigate the relationship between the duration of blood-brain barrier disruption and extent of demyelination in new multiple sclerosis lesions. Silver N; Lai M; Symms M; Barker G; McDonald I; Miller D J Neurol; 1999 Aug; 246(8):728-30. PubMed ID: 10460455 [No Abstract] [Full Text] [Related]
9. Iron-based superparamagnetic nanoparticle contrast agents for MRI of infection and inflammation. Neuwelt A; Sidhu N; Hu CA; Mlady G; Eberhardt SC; Sillerud LO AJR Am J Roentgenol; 2015 Mar; 204(3):W302-13. PubMed ID: 25714316 [TBL] [Abstract][Full Text] [Related]
10. [Cutting-edge of advanced MRI for demyelinating diseases]. Harada M Rinsho Shinkeigaku; 2013; 53(11):1094-6. PubMed ID: 24291889 [TBL] [Abstract][Full Text] [Related]
11. MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study. Verhey LH; Branson HM; Shroff MM; Callen DJ; Sled JG; Narayanan S; Sadovnick AD; Bar-Or A; Arnold DL; Marrie RA; Banwell B; Lancet Neurol; 2011 Dec; 10(12):1065-73. PubMed ID: 22067635 [TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo characterization of several functionalized ultrasmall particles of iron oxide, vectorized against amyloid plaques and potentially able to cross the blood-brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imaging. Ansciaux E; Burtea C; Laurent S; Crombez D; Nonclercq D; Vander Elst L; Muller RN Contrast Media Mol Imaging; 2015; 10(3):211-24. PubMed ID: 25284012 [TBL] [Abstract][Full Text] [Related]
13. Neuroimaging of multiple sclerosis, acute disseminated encephalomyelitis, and other demyelinating diseases. Bester M; Petracca M; Inglese M Semin Roentgenol; 2014 Jan; 49(1):76-85. PubMed ID: 24342677 [No Abstract] [Full Text] [Related]
15. Enhancing our understanding of multiple sclerosis: tracking contrast-enhancing plaques with MR imaging. Maravilla KR AJNR Am J Neuroradiol; 2001 Apr; 22(4):601-3. PubMed ID: 11290465 [No Abstract] [Full Text] [Related]
16. In vivo characterization of the multiple sclerosis plaque by magnetic resonance imaging and spectroscopy. Larsson HB Acta Neurol Scand Suppl; 1995; 159():1-44. PubMed ID: 7625161 [No Abstract] [Full Text] [Related]
17. Pluriformity of inflammation in multiple sclerosis shown by ultra-small iron oxide particle enhancement. Vellinga MM; Oude Engberink RD; Seewann A; Pouwels PJ; Wattjes MP; van der Pol SM; Pering C; Polman CH; de Vries HE; Geurts JJ; Barkhof F Brain; 2008 Mar; 131(Pt 3):800-7. PubMed ID: 18245785 [TBL] [Abstract][Full Text] [Related]
18. Superparamagnetic iron oxide nanoparticles: diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review. Weinstein JS; Varallyay CG; Dosa E; Gahramanov S; Hamilton B; Rooney WD; Muldoon LL; Neuwelt EA J Cereb Blood Flow Metab; 2010 Jan; 30(1):15-35. PubMed ID: 19756021 [TBL] [Abstract][Full Text] [Related]
19. The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review. Karussis D J Autoimmun; 2014; 48-49():134-42. PubMed ID: 24524923 [TBL] [Abstract][Full Text] [Related]
20. Uncovering and characterizing multiple sclerosis lesions: the aid of fluid-attenuated inversion recovery images in the presence of gadolinium contrast agent. Bagnato F J Neuroimaging; 2009 Jul; 19(3):201-4. PubMed ID: 19187471 [No Abstract] [Full Text] [Related] [Next] [New Search]